BioCentury
ARTICLE | Finance

Banker tracks

Biotech investor, banker and analyst personnel changes

October 7, 2013 7:00 AM UTC

Maurice Laudy and Machiel Van Oostveen departed from the healthcare sector of ABN AMRO to start an independent healthcare advisory firm. Laudy had been an executive director and head of healthcare, while Van Oostveen was an executive director.

Yale Jen joined the healthcare research team at Laidlaw & Co.as a managing director. He was a senior research analyst at Roth Capital focused on the biotechnology sector...